Managers
A consortium consisting of Macquarie Corporate Holdings (Macquarie Capital) and InfraVia II Invest, managed by InfraVia Capital Partners (InfraVia) have acquired a 39.39 per cent equity interest in Metro de Malaga from Cajamar (18.86 per cent), Cointer Concesiones (11.96 per cent) and Sando Concesiones (8.57 per cent).
On completion, the buyers will represent the largest private shareholder in the Company which has been successfully operating since July 2014.
The company was granted a long term concession by the Government of Andalusia to provide transportation to those 200,000 Malaga residents who live within 500 meters of a station. Today, Metro
Mid-market private equity specialist Graphite Capital has provided development capital to Aero Technics, a civil aircraft maintenance business focusing on cabin services, to acquire Airbase Interiors, which specialises in the repair and dry cleaning of aircraft seats.
Aero Technics was founded in 2002 by its present chief executive, Steve Cloran. He has long experience in the aircraft services industry and will continue to lead the combined business, which will have operations in Manchester, Dubai, Heathrow and Gatwick with a customer base that spans many leading airlines.
The UK civil aircraft maintenance market is estimated to be worth £1.7 billion
Alternative Investment Capital Limited (AIC), a Japanese management firm specialising in private equity investments, has chosen eFront's flagship FrontInvest solution in combination with its eFront Investor Cloud (EIC) solution to integrate the firm's operations and streamline its alternative investments data workflows.
FrontInvest is an end-to-end solution for both investors and fund managers. EIC provides services to limited partners by collecting and validating performance data from fund managers.
AIC was founded in 2002 as an investment management firm in Japan focusing exclusively on alternative assets. The firm is headquartered in Tokyo and primarily serves Japanese institutional investors and pension funds.
The Universities Superannuation Scheme (USS) has sold a 40% shareholding in UK motorway services provider Moto to funds advised by CVC Capital Partners (CVC).
This will be the second investment made from CVC’s Strategic Opportunities Platform, which has been established in response to growing demand from large investors to be able to invest for the long term in stable, high quality businesses.
Moto, which was founded in 2001, operates in 45 locations throughout the UK and employs over 6,000 staff.
Tim Moss, CEO of Moto, says: “I am very pleased that such an experienced investor as CVC has
New York-based private equity firm Aquiline Capital Partners has made an investment in OmegaFi, a provider of financial, membership management, and fundraising software and support solutions for college fraternities and sororities across the United States.
OmegaFi's suite of services helps fraternal organisations at the local and national levels bill and collect dues and rent, manage rosters and records, pay bills and employees, file tax returns, build websites, publish newsletters, conduct fundraising campaigns and process payments.
"OmegaFi is the dominant player in a very specialised yet growing market, and a strong addition to our roster of innovative financial technology portfolio
Crescent Capital Group has held the final close of the Crescent European Specialty Lending Fund with more than EUR500 million of investor commitments, bringing the total deployable capital available to the strategy to approximately EUR650 million.
Since October 2014, the fund has committed approximately one-third of its capital across several investments.
“I am pleased with the growth of our European strategy both in terms of the significant capital we now have available as a result of this fundraise as well as the success of the transactions we have already closed in this fund,” says Christine Vanden Beukel (pictured), Managing
Charter NEX Films, a producer of high-polyethylene films, is pleased to announce that it has completed the acquisition of Optimum Plastics, in an all-cash transaction for an undisclosed amount.
Charter NEX supplies flexible packaging converters with a broad array of products, from monolayer to high barrier films, for the retail food, consumer products, industrial, and medical markets. Charter NEX is well-regarded for its best-in-class quality standards and manufacturing performance. The company is owned by Pamplona Capital Management, LLP (“Pamplona”), a global private equity investment firm, and management.
“We are excited to be joining forces with Optimum Plastics,” says Kathy
Edesix, a UK-based provider of body worn camera (BWC) solutions, has secured further investment from Panoramic Growth Equity, who have been backing the company since 2014.
Edesix has raised a further GBP750,000 to fund expansion into new markets and to continue the development of its technology, product range and sales infrastructure both in the UK and overseas.
Headquartered in Edinburgh, UK and established in 2002, Edesix manufactures BWC’s for those in public facing roles, helping to improve safety, while producing compelling legal evidence when needed. Edesix currently provides VideoBadges and VideoManager footage management software to local authority enforcement teams,
The John Laing Environmental Asset Group (JLEN) has acquired Burton Wold Extension wind farm from John Laing Group (John Laing) for a cash consideration, including working capital, of GBP21.8 million.
Burton Wold Extension wind farm is located near Burton Latimer in Northamptonshire and comprises nine General Electric 1.6MW-100 turbines with a total generating capacity of 14.4MW and is accredited for 0.9 ROCs. The site has been operational since September 2014.
This acquisition, which was agreed in accordance with the First Offer Agreement between John Laing and JLEN, brings the total capacity of the renewable energy assets in the JLEN
GHO Capital, the European specialist healthcare investor, today announces the acquisition of Quotient Clinical (Quotient or the Company), a provider of outsourced, early-stage drug development services to the pharmaceutical industry.
Headquartered in the UK and employing over 280 professionals, Quotient Clinical enables pharmaceutical and biotechnology customers to improve research and development productivity and accelerate drug development timelines.
Quotient Clinical’s Translational Pharmaceutics® platform offers a differentiated service proposition in the form of an integrated approach to drug formulation development, “real-time” manufacturing and clinical testing within a single location. With significant time and cost savings, customers are able to bring drug
Events
12 November, 2026 – 8:00 am
12 November, 2026 – 5:00 pm
